Arctic

The Arctic Group is a leading, independent provider of financial services

Companies and services

Download the
Arctic Circle app

Launching New Arctic Online


Learn More

Bestill LEI-nummer

Imøtekom kravet for investeringsselskap i 2018

Les mer

Inviduell Pensjonssparing

Du sparer. Vi investerer. Så enkelt.

Les mer

News and latest activity

News and latest activity

Thu 21 Feb 2019

Offerings - Norwegian Air Shuttle ASA – Rights Issue

Arctic Securities is acting as Joint Bookrunner in relation to the Rights Issue in Norwegian Air Shuttle ASA

Tue 19 Feb 2019

News - A very good start in healthcare

Our very own Ulrica Slåne Bjerke was today interviewed by EFN talking about a very positive January performance in the healthcare and biotech sector. In Børslunch, Ulrica talks about companies like Eli Lilly, Loxo, Gilead and Nordic Nanovector along with Mårten Steen from Healthcap.

Wed 13 Feb 2019

Offerings - Eurocine Vaccines AB (publ) – Rights issue of SEK 15.6m

Arctic Securities is acting as financial advisor in relation to the 90 percent secured rights issue of SEK 15.6m for the Swedish listed vaccine company Eurocine Vaccines AB (publ). Eurocine Vaccines AB (publ) is referred to as “Eurocine Vaccines” or “the Company”. Shareholders have pre-emptive rights to subscribe for shares. Three (3) existing shares held on the record date of March 21, 2019, entitles to five (5) new shares. Subscription price of SEK 0.11 per share. The subscription period runs 25 March – 8 April, 2019. The rights issue is secured up to 90 percent through subscription- and guarantee undertakings. A Swedish memorandum and subscription note will be available before the subscription period on Eurocine Vaccines website, www.eurocine-vaccines.com and Arctic Securities website.

Thu 14 Feb 2019

News - Vaccibody AS - Private Placement - NOK 230 million

Arctic Securities acted as Joint Bookrunner in relation to the Private Placement of NOK 230 million in Vaccibody AS.

Latest from Twitter

;